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Recently, the South African Medical Journal published an article 
entitled ‘Vaccines: SA’s immunisation programme debunked’.[1] The 
article extensively quotes someone who has resigned from the 
Department, and to give credence to the avalanche of negativity about 
the country’s Expanded Programme on Immunisation (EPI), the 
former employees of the Department are posted as the top National 
Department of Health (NDoH) EPI managers with substantial years 
of experience and, supposedly, expertise.
When a journalist publishes a story of the views of the former 
employees and does not seek the voice of those who are still serving, 
one will not be able to know whether what is reported is fact or 
sour grapes. Good journalism is balanced journalism – giving the 
protagonists, so to speak, equal opportunity to tell their versions of 
the story. 
The resignation of the two employees did not create a crisis for 
the EPI for two reasons: (i) the implementation of EPI is done 
at provincial level, and the NDoH’s responsibility is to develop 
policies and monitor their implementation; and (ii) the supervisors 
of these two former employees have years of experience, not only in 
immunisation but child health as a whole, which is more than just 
basic EPI. This is of paramount importance because integration 
is needed for efficiencies and cost-effectiveness in the delivery of 
health programmes. Their years of experience certainly contribute 
to institutional memory. 
Staffing of the EPI unit at the national office has been priori-
tised. Posts were advertised following the resignation of the two 
employees, interviews have been conducted and the process of 
appointment is being finalised. Some of the incumbents have 
taken up the posts and others are still going through the process. 
All the posts will be filled, including that of the medi cal officer.
Human resources for health
With the Sustainable Development Goals (SDGs), the global 
commu nity sees greater than ever consensus about the crucial 
role that the health workforce plays in realising goals to achieve 
universal health coverage. Qualified health workers, trained to work 
in effective teams within and across professional cadres to address 
the biomedical and social determinants of health, are critical to 
achieving health goals. While great progress has been made in 
maternal and child health and HIV/AIDS, continued shortages of 
adequately trained health workers raise the question of whether 
health professional education (HPE) systems are producing the 
health workforce needed to meet outstanding and emerging global 
health challenges.
There is recognition by the World Health Organization (WHO) 
and other health scientists across the world that the train ing of health 
professionals does not meet the health needs of the 21st century.[2,3] 
Training of health professionals is based on outdated, fragmented, 
and content-oriented curricula that produce graduates with nar-
row contextual understanding and insufficient knowledge, skills, 
and competencies to understand social and other determinants of 
health and burden of disease. This outdated training has led to: poor 
teamwork and inadequate colla boration within and across health 
professional cadres; episodic encounters with patient illnesses rather 
than continuous and holistic healthcare; a predominant hospital ori-
entation at the expense of primary care; an imbalance between health 
workforces and health needs; and weak leadership in improving 
health system performance.[4]
The achievement of the health-related objectives of the National 
Development Plan (NDP) and SDGs is contingent on a skilled, 
compet ent, multiprofessional and interprofessional health workforce 
working synergistically to address the quadruple burden of disease.[5]
The NDoH is working towards a health workforce that has the 
right skills, and works in the right place at the right time to provide 
the right services to the right people.[4] Above all, the Department 
is encouraging integrated teams that are comprised of team players. 
Persons who elevate themselves beyond team work often find it 
difficult to fit into the new culture.
The effectiveness of the EPI in  
South Africa (SA) 
Scientific literature on the effectiveness of EPI in SA is prolific and 
includes reports of studies done by independent researchers.[6-8] 
Madhi[9] has reported that in SA under-5 childhood deaths 
increased from 74 753 in 2000, peaked at 89 418 in 2005 and declined 
to 47 409 in 2013. He attributes this to the introduction of the EPI. 
HEALTHCARE DELIVERY
The Expanded Programme on Immunisation in
South Africa: A story yet to be told 
N R Dlamini,1 BSc, MB ChB, MMed (Paed); P Maja,2 BA Hons 
1  Child, Youth and School Health: National Department of Health, Pretoria, South Africa
2  Communication and Stakeholder Engagement: National Department of Health, Pretoria, South Africa
Corresponding author: P Maja (majap@health.gov.za)
During the past two decades, immunisation has saved millions of lives and prevented countless illnesses and disabilities in South Africa 
(SA). However, vaccine-preventable diseases are still a threat. A vaccine-preventable disease that might lead to a 1- or 2-week illness in an 
adult, could prove deadly for infants, children or elderly people. Vaccination protects oneself and one’s family. For example, adults are the 
most common source of pertussis (whooping cough) infection in infants, which can be deadly for the latter. This article demonstrates the 
commitment of the SA government to immunisation, highlights key milestones of the Expanded Programme on Immunisation (EPI) and 
dispels the myth that the EPI in SA is in shambles.
S Afr Med J 2016;106(7):675-677. DOI:10.7196/SAMJ.2016.v106i7.10956
IN PRACTICE
676       July 2016, Vol. 106, No. 7
Immunisation averts some 2.5 million premature deaths a year 
according to estimates and protects millions of children from illness 
and disability. Parents and children attending a clinic in SA are among 
those today who will reap the benefits of routine immunisation from 
the first days of life.[9] 
South Africa now has 11 antigens in the EPI schedule, including 
the most recently introduced human papillomavirus (HPV) vaccine 
for protection of young girls against cancer of the cervix that may 
affect them later in life. The immunisation programme has come a 
long way since it was launched in 1974, when there were only six 
vaccines in the schedule: diphtheria, pertussis and tetanus (DPT), 
measles, polio and Bacillus Calmette-Guérin (BCG) for protection 
against tuberculosis.[6] 
The EPI in SA has made significant achievements in the last few 
decades, including:
• Polio has been eliminated in SA, with a last case found in 1989. 
• Other conditions that are under control are diphtheria and 
pertussis, commonly known as whooping cough.
• SA has been in the forefront of introducing new vaccines. In 
1995 the country introduced hepatitis B (hep B) vaccine. In 1999 
Haemophilus influenzae type b (Hib) vaccine was introduced. 
2009 saw the introduction of pneumococcal vaccine (PCV) 
and rotavirus vaccine (RV), and most recently in 2014 HPV to 
prevent cervical cancer. On the continent, SA has been one of the 
first countries to introduce these vaccines – all fully funded by 
government.  The programme continues to improve as evidenced 
by the fact that early in 2015 pentavalent vaccine was phased out 
and replaced by the more baby-friendly hexavalent so that the baby 
is only pricked once to receive six antigens.
When SA introduced the PCV and RV, the Department asked the 
National Institute for Communicable Diseases (NICD) to establish 
a surveillance system and to study the impact of these new vaccines 
on incidence of pneumonia and diarrhoea. The NICD reports that 
there has been a >40% reduction in pneumococcal diseases across 
all ages. The greatest decline is among children <2 years of age, the 
age group that carries the highest levels of the disease. In addition the 
NICD found that there was a 34% decline in pneumococcal disease 
in people ≥45 years old. Besides the impact of vaccine on pneumonia, 
the NICD reported that the vaccine has an effect on antimicrobial 
resistance – which is a global problem and if not urgently addressed 
can reduce the effectiveness of the antibiotics that are currently used. 
The pneumococcus vaccine contributes to a significant decline in 
penicillin, ceftriaxone (Rocephin) and multidrug-resistant strains of 
pneumococcus.[7,10]
Similar surveillance on the impact of the RV shows that the vaccine 
has resulted in a 40% reduction in the hospitalisation of children 
with diarrhoea (attributable to all causes) and 60% reduction in 
hospitalisations from diarrhoea that is caused by rotavirus. 
In 2014 the Department of Health introduced the HPV for all 
girls in grade 4 who are ≥9 years old. The HPV vaccine protects 
from cancer of the cervix when they are older women. It is known 
that cancer of the cervix is the most common cancer among women 
in SA and predominantly affects black women, at an increasingly 
younger age. Cancer of the cervix has debilitating complications and 
often severely compromises the quality of life of those affected before 
they eventually succumb to it. It is estimated that 6 000 women a year 
in SA contract cervical cancer and about half of them die from the 
disease. 
SA was the first country on the African continent to introduce 
the two new vaccines. PCV has now been introduced in other 
countries in Africa such as Kenya and Rwanda that are supported 
by the Global Alliance for Vaccines and Immunisation (GAVI). 
SA remains the only country in the WHO Africa region that self-
finances vaccines.[9]
The introduction of PCV and RV is a significant public health 
milestone for the country and the continent. Furthermore, it points 
to the leadership role that SA has taken on the continent with the 
introduction of new and underutilised vaccines, dating back to 1995 
with the introduction of hep B and, in 1999, Hib vaccines.
Sound decision-making process
Given the complexity of the introduction of new vaccines and that 
such decisions relate to an important public health programme, 
it is crucial that these decisions which establish immunisation 
policies are well informed, unbiased, evidence based and locally 
relevant. This has been the basis of the formation of national 
immunisation technical advisory groups (NITAGs) in many 
countries, particularly in developed countries where these groups 
are well established. SA has a functional NITAG, referred to as 
the National Advisory Group on Immunisation (NAGI). NAGI is 
effective as a source of information and an advisory body to the 
NDoH. This is evidenced by its major role in the introduction of 
PCV and RV into the EPI.[8]
When there is an intention to add vaccines to the EPI, several 
factors need to be taken into consideration. These include the burden 
and significance of the disease within the country, whether there is 
a safe and effective vaccine available, what the cost-benefit of the 
vaccine would be and whether the country could afford to implement 
it, and finally, whether the vaccine could be incorporated practically 
into the national EPI programme.
Political stewardship
Political leadership in the public health sector became more pro-
nounced in April 2008 when there was a spike in child deaths in the 
rural Ukhahlamba District (currently Joe Gqabi) of the Eastern Cape 
Province, with 70% of 140 deaths reportedly due to gastroenteritis, 
pneumonia and malnutrition. Rather than any specific disease 
outbreak, the deaths were mainly attributable to weaknesses in the 
health system.
Widespread media coverage prompted the Ministry of Health to 
travel to the Ukhahlamba District to attend to the crisis and offer 
support. Propelled by the Ukhahlamba deaths, public concern and 
advocacy efforts to get government to financially and politically 
commit to the introduction of the vaccines, the Health Minister 
announced to the 61st World Health Assembly in May 2008 in 
Geneva, that the vaccines against pneumococcal and rotavirus 
disease would be introduced within 3 months. Instead of a 2-year 
lead in, the plan had to be fast-tracked to meet the deadlines, and 
this had huge financial and programmatic implications as both 
vaccines would be introduced sooner and simultaneously with the 
new pentavalent vaccine.
To this day, political commitment is steadfast in all priority 
programmes.
Programme performance
The programme indicators are routinely monitored using District 
Health Information Software (DHIS), whereby the denominators 
are the Statistics South Africa (StatsSA) mid-year estimates. The 
denominators for the HPV vaccine are obtained from the Department 
of Basic Education.
Currently the country has embarked on the Demographic and 
Health Survey, which will provide immunisation coverage data as 
one of its deliverables.
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Milestones in EPI in SA
Several milestones have been reached in the history of the EPI in SA:
• 1995: hep B vaccine was introduced
• 1999: Hib vaccine was introduced
• 2000: converted from percutaneous to intradermal route for BCG 
vaccine
• 2002: neonatal tetanus was eliminated
• 2006: SA was declared polio-free; last reported case was in 1989
• 2008: CPV and RV vaccines were introduced
• 2009: SA first African country and middle-income country to 
introduce PCV into public immunisation programme, in April 
(USD20 per dose = ZAR600 million annually)[9]
• 2009: SA first African country to introduce RV vaccine into public 
immunisation programme, in August (USD7.5 per dose = ZAR150 
million annually)[9]
• 2009: SA switched from whole-cell pertussis vaccine to acellular 
pertussis vaccine with the introduction of the pentavalent vaccine 
(5-in-1)
• 2015: SA became the first country in Africa to introduce a fully 
liquid hexavalent vaccine (6-in-1) by replacing the pentavalent 
(5-in-1) and hep B vaccines.[9]
The EPI is a priority programme of government. It is not going to die 
because one or two of its officials have resigned from the national office. 
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